Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Hanna Ashraf
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2017-06-30$0.13/sh+500$63→ 12,420 total - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+3,600$450→ 16,020 total - Exercise/Conversion
Restricted Share Units
2017-07-01−3,600→ 0 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying) - Exercise/Conversion
Restricted Share Units
2017-06-30−500→ 0 totalExercise: $0.13From: 2017-06-30Exp: 2019-07-01→ Ordinary Shares (500 underlying)
Holdings
- 1,500(indirect: By Trust)
Ordinary Shares